Robert C. Brunham is the head of the UBCCDC Vaccine Research Laboratory at BCCDC and a professor emeritus of medicine at UBC. Until 2014, he was also the executive and scientific director of BCCDC.
Dr. Brunham's research is in the field of immunology, genomics, and the epidemiology of sexually transmitted diseases. His research focuses on developing a vaccine for Chlamydia trachomatis.
Recently, in collaboration with UBC scientists, he pioneered a cutting edge proteomic approach to chlamydia vaccine development, called immunoproteomics, which has generated international interest and financial support from the National Institutes of Health.
Dr. Brunham holds a University of Washington post-doctoral fellowship in infectious disease and has a medical degree from UBC.
While head of the British Columbia Centre for Disease Control he pioneered genomic approaches for emerging and re-emerging infectious diseases including SARS, pandemic Influenza, Chlamydia trachomatis, Cryptococcus gattii and tuberculosis, which has globally influenced how public health institutions approach the problem of emerging and re-emerging infectious diseases. His contribution to prevention and control of Chlamydia trachomatis and SARS has been widely recognized with honours and awards including the Order of British Columbia and the CIHR research partnership award. He was elected to the Royal Society of Canada and has over 300 peer-reviewed publications with an H-index of 83 and over 27,000 citations.
- For Dr. Brunham's publications, see PubMed.
- For citations of Dr. Brunham's publications, see Google Scholar.